Your browser doesn't support javascript.
loading
Using Multi-Modal Electronic Health Record Data for the Development and Validation of Risk Prediction Models for Long COVID Using the Super Learner Algorithm.
Jin, Weijia; Hao, Wei; Shi, Xu; Fritsche, Lars G; Salvatore, Maxwell; Admon, Andrew J; Friese, Christopher R; Mukherjee, Bhramar.
Affiliation
  • Jin W; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Hao W; Center for Precision Health Data Science, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Shi X; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Fritsche LG; Center for Precision Health Data Science, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Salvatore M; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Admon AJ; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Friese CR; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Mukherjee B; Center for Precision Health Data Science, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
J Clin Med ; 12(23)2023 Nov 25.
Article in En | MEDLINE | ID: mdl-38068365
ABSTRACT

BACKGROUND:

Post-Acute Sequelae of COVID-19 (PASC) have emerged as a global public health and healthcare challenge. This study aimed to uncover predictive factors for PASC from multi-modal data to develop a predictive model for PASC diagnoses.

METHODS:

We analyzed electronic health records from 92,301 COVID-19 patients, covering medical phenotypes, medications, and lab results. We used a Super Learner-based prediction approach to identify predictive factors. We integrated the model outputs into individual and composite risk scores and evaluated their predictive performance.

RESULTS:

Our analysis identified several factors predictive of diagnoses of PASC, including being overweight/obese and the use of HMG CoA reductase inhibitors prior to COVID-19 infection, and respiratory system symptoms during COVID-19 infection. We developed a composite risk score with a moderate discriminatory ability for PASC (covariate-adjusted AUC (95% confidence interval) 0.66 (0.63, 0.69)) by combining the risk scores based on phenotype and medication records. The combined risk score could identify 10% of individuals with a 2.2-fold increased risk for PASC.

CONCLUSIONS:

We identified several factors predictive of diagnoses of PASC and integrated the information into a composite risk score for PASC prediction, which could contribute to the identification of individuals at higher risk for PASC and inform preventive efforts.
Key words

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Language: En Journal: J Clin Med Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Language: En Journal: J Clin Med Year: 2023 Document type: Article